The global burden of atherosclerotic vascular disease
Gregg C Fonarow
Correspondence UCLA Division of Cardiology, David Geffen School of Medicine at UCLA, Room 67–120 CHS, 10833 Le Conte Avenue, Los Angeles, CA 90095–1679, USA
Email gfonarow@mednet.ucla.edu
This article has no abstract so we have provided the first paragraph of the full text.
Cardiovascular disease is, or will soon be, the leading cause of death worldwide, and carries a substantial international burden of morbidity, diminished quality of life, disability, lost productivity, and economic cost.1 Despite this disturbing prospect, few data exist on cardiovascular event rates and contemporary management of patients with established atherosclerotic vascular disease in the outpatient setting. The REACH registry was established to study risk factor control, and patient characteristics, treatment, and outcomes in a large international cohort of outpatients with a history of atherothrombosis or at high risk of developing this condition.2 With over 68,000 patients from 44 different countries, the data in the REACH registry is ideal for the evaluation of the contemporary cardiovascular risk associated with atherosclerotic vascular disease at an international level.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
